Antithrombotic treatment pattern in newly diagnosed atrial fibrillation patients and 2-year follow-up results for dabigatran-treated patients in the Africa/Middle-East Region: Phase II results from the GLORIA-AF registry program-Reference-Cited by-同舟云学术

Antithrombotic treatment pattern in newly diagnosed atrial fibrillation patients and 2-year follow-up results for dabigatran-treated patients in the Africa/Middle-East Region: Phase II results from the GLORIA-AF registry program

Published:2021-06 Issue: Volume:34 Page:100763
ISSN:2352-9067
Container-title:IJC Heart & Vasculature
language:en
Short-container-title:IJC Heart & Vasculature

Author:

Azar Rabih R.^ORCID,Ragy Hany I.,Kozan Omer,El Khuri Maurice,Bazergani Nooshin,Marler Sabrina,Teutsch Christine,Ibrahim Mohamed^ORCID,Lip Gregory Y.H.,Huisman Menno V.

Funder

Boehringer Ingelheim GmbH

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference15 articles.

1. Atrial fibrillation: strategies to control, combat, and cure;Peters;Lancet,2002

2. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study;Wolf;Stroke,1991

3. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study;Go;JAMA,2001

4. Effectiveness and safety of standard-dose nonvitamin K antagonist oral anticoagulants and warfarin among patients with atrial fibrillation with a single stroke risk factor: a nationwide cohort study;Lip;JAMA Cardiol.,2017

5. Advancement in antithrombotics for stroke prevention in atrial fibrillation;Umer Usman;J Interv Card Electrophysiol.,2008

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent highlights from the International Journal of Cardiology Heart & Vasculature on challenges for adequate stroke prevention in patients with atrial fibrillation;IJC Heart & Vasculature;2023-10

2. Antithrombotic Usage, Including Three-Year Outcomes With Dabigatran and Vitamin K Antagonists for Atrial Fibrillation, in Eastern Europe: A Descriptive Analysis From Phase 3 of the GLORIA-AF Registry;American Journal of Therapeutics;2023-01-10

3. One-Year Clinical Outcome in Middle Eastern Patients with Atrial Fibrillation: The Jordan Atrial Fibrillation (JoFib) Study;International Journal of Vascular Medicine;2022-04-13

4. Demographics and Risk Profile of Elderly Middle Eastern Patients with Atrial Fibrillation: The Jordan Atrial Fibrillation (JoFib) Study;Vascular Health and Risk Management;2022-04

5. Stroke prevention of atrial fibrillation: Improving geographic under-use of contemporary antithrombotic approaches remains a challenge;IJC Heart & Vasculature;2021-06